Meet Cromos Pharma at SCOPE 2022

Cromos Pharma is delighted to be taking part in SCOPE Summit 2022  which will take place February 7-10, 2022 in Orlando, FL. We look forward to meeting partners and potential clients to hear about your clinical program plans.

We look forward to sharing with you the advantages of partnering with Cromos Pharma including:
  • International expertise combined with in-depth regional knowledge in Central and Eastern Europe (300+ clinical trials conducted in 70+ indications). 
  • Extensive PI/site and patient network (40,000+ patients enrolled from nearly 2,500 trial sites).
  • Unparalleled patient recruitment – our team met or shortened project timelines in 95% of conducted trials.
  • Extremely short startup timelines (e.g. Georgia where we assure a study launch in less than 2 months).
  • Expertise in innovative, generics and biosimilar global studies (NDAs, ANDAs, BLAs, 505b2).
  • Regulatory inspections and audits that attest to the highest quality of data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
  • Clinical Development Strategy – we provide expert guidance on study design, favorable venues, local and global landscape to improve study outcomes.
  • You can also find out more about availing of Cromos Pharma’s special programs including:


    Free Feasibility Reports for Sponsors considering expanding their clinical trials into Central and Eastern Europe. You confidentially provide us with your protocol, synopsis, or trial outline and in just two weeks our expert team will deliver a detailed feasibility report including: 

    • Competitive landscape 
    • Review of local standards of care 
    • Historical recruitment statistics 
    • Regulatory requirements and timelines 
    • Realistic recruitment projections


    “No Patients - No Payment” is Cromos Pharma’s proprietary risk sharing program through which we give our assurance that your enrollment goals, budgets, and timelines will be met.  Simply put, if we don’t recruit – you don’t pay. 

    About us

    Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range  of therapeutic areas. Our expert team, comprising 95% MDs, has expansive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.

    Cromos Pharma has experience in delivering success in studies from biosimilars and generics to successfully managing oncology, neurology, and dermatology clinical trials. Our team provides full-service solutions to international pharma and biotech in high-recruiting regions, assuring exceptional quality data. Cromos Pharma combines global expertise, with in-depth experience and knowledge, in Central and Eastern Europe to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of trials conducted. 

    We provide accelerated study  start-up timelines in our regions of operation. We regularly achieve regulatory approvals in Georgia within two months of project signing (four months in Russia, and in less than five months  in Ukraine). Regulatory inspections and site audits also attest to the highest quality of our clinical data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection). 

    Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA.

    Arrange a meeting with Cromos Pharma's US Business Development Director, Nicole Brenna by emailing

    Other Events:

    Meet us during BIO-Europe Spring 22 -25 March

    Cromos Pharma is delighted to be participating in BIO-Europe Spring (22 - 25 March, 2021). Set up a meeting with us today!

    Meet with us at DIA Europe 15 - 19 March

    Cromos Pharma is looking forward to taking part in the upcoming DIA Europe conference (15 – 19 March 2021).  A highly collaborative event, it’s a great chance to meet with future partners and hear from innovators across the entire life sciences spectrum. 


    Cromos Pharma at OCT West Coast 2021

    Outsourcing in Clinical Trials West Coast 2021 is just around the corner (24 – 25 February) and we are looking forward to participating in this year’s virtual event. 

    Visit our Virtual Booth at the JP Morgan Healthcare Conference 2021

    This year the JP Morgan Healthcare Conference is going virtual and so are we! We have been meeting you at this event for the past 11 years and there is no way we are going to break with that tradition this year.  So we are delighted to be hosting a VIRTUAL CROMOS PHARMA BOOTH January 11th through 14th from 8 am to 5 pm (PST).

    Happy Hanukkah from Cromos Pharma

    Wishing you all a wonderful season filled with light, hope and health! From all of us at Cromos Pharma #hanukkah #happyholidays

    Cromos Pharma at The San Antonio Breast Cancer Symposium 2020

    We are delighted to taking part again in this year's San Antonio Breast Cancer Symposium (8-11 December). We invite you to arrange a meeting with our team to discuss how we can support your trials in this area. 


    Meet Cromos Pharma at the 62nd ASH Annual Meeting & Exposition

    Cromos Pharma is delighted to be participating again this year at the 62nd ASH Annual Meeting & Exposition 5-8 December, 2020, the premier event for malignant and non-malignant hematology. We would like to invite you to set up an online meeting with us. 

    Join Cromos Pharma at World Orphan Drug Congress-Europe 2020

    We are just one week away from the virtual World Orphan Drug Congress Europe 2020. Cromos Pharma is delighted to be participating in this event and invite you to join us from 2-5 November. Register here and connect with us via the partnering platform or email to set up a meeting.

    Cromos Pharma at GRx+Biosims November 9-11, 2020

    Cromos Pharma is delighted to be participating in the upcoming GRx+Biosims 2020 (9-11 November). We look forward to this virtual event which is consistently one of the highlights of the year for biosimilar and generic sectors.

    Cromos Pharma at BIO-Europe Digital Oct 26-29

    Cromos Pharma is delighted to be participating in BIO-EUROPE Digital, 26 -29 October. It promises to be an exciting event with themes including innovation and digital health in the context of the ongoing pandemic and stimulating sessions focusing on collaboration and partnering. We look forward to connecting with you at the event.